Physician extenders for cost-effective management of hypercholesterolemia
Journal of General Internal MedicinePublished 1 May 1996
Gordon Schectman, Nancy Wolff, James C. Byrd, Janet G. Hiatt, Arthur J. Hartz
Citations49
SJR quartileQ1
SJR score1.99
SNIP1.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Although more expensive than usual care, the greater effectiveness of physician extenders implementing cholesterol treatment algorithms resulted in more cost-effective therapy.
Abstract
Although more expensive than usual care, the greater effectiveness of physician extenders implementing cholesterol treatment algorithms resulted in more cost-effective therapy.
Keywords
Medicine
Clinical ChemistryEstimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
32,475 Citations1972William T. Friedewald, Robert I. Levy +1 more
A method for estimating the cholesterol content of the serum low-density lipoprotein fraction (Sf0-20) is presented and comparison of this suggested procedure with the more direct procedure, in which the ultracentrifuge is used, yielded correlation coefficients of .94 to .99.
JAMASummary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
27,886 Citations1993Scott M. Grundy
Dairy therapy remains the first line of treatment of high blood cholesterol, and drug therapy is reserved for patients who are considered to be at high risk for CHD, and the fundamental approach to treatment is comparable.
Clinical ChemistryEnzymatic Determination of Total Serum Cholesterol
9,168 Citations1974Charles C. Allain, Lucy S Poon +3 more
An enzymatic method is described for determination of total serum cholesterol by use of a single aqueous reagent and has excellent precision.
Cellular Physiology and BiochemistryAntihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
5,950 Citations2015Saritha Marella, Dilip Rajasekhar Maddirela +3 more
Mcy protein can alleviate hyperlipidemia and help manage diabetes by stimulating insulin secretion without evident toxic effects on liver and kidney and showed the pancreatic islet regeneration in Mcy treated rats.
EpidemiologyNo Adjustments Are Needed for Multiple Comparisons
5,844 Citations1990Kenneth J. Rothman
A policy of not making adjustments for multiple comparisons is preferable because it will lead to fewer errors of interpretation when the data under evaluation are not random numbers but actual observations on nature.
JAMAThe Lipid Research Clinics Coronary Primary Prevention Trial Results
2,745 Citations1984
Adherence to medication was associated with reduced incidence of CHD only when accompanied by falls in TOTAL-C and LDL-C levels, and small increases in high-density lipoprotein cholesterol levels, which accompanied cholestyramine treatment, independently accounted for a 2% reduction in CHD risk.
The LancetRandomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
2,395 Citations1994SCANDINAVIANSIMVASTATINSURVIVAL
This study shows that long-term treatment with simvastatin is safe and improves survival in CHD patients, and a 37% reduction in the risk of undergoing myocardial revascularisation procedures.
Archives of Internal MedicineReport of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
2,298 Citations1988DeWitt S. Goodman
New guidelines for the treatment of high blood cholesterol in adults 20 years of age and over are provided and which patients should go on to have lipoprotein analysis, and which should receive cholesterol-lowering treatment on the basis of their low density lipop protein levels and status with respect to other coronary heart disease risk factors are detailed.
CirculationEffects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels
844 Citations1995J. Wouter Jukema, Albert V.G. Bruschke +8 more
In symptomatic men with significant coronary atherosclerosis and normal to moderately elevated serum cholesterol, less progression of coronary atheosclerosis and fewer new cardiovascular events were observed in the group of patients treated with pravastatin than in the placebo group.
Annals of Internal MedicineA Case-Management System for Coronary Risk Factor Modification after Acute Myocardial Infarction
743 Citations1994Robert F. DeBusk, Nancy Houston Miller +15 more
This randomized, controlled trial compared the effectiveness of a physician-directed, nurse-managed, home-based case-management system for coronary risk factor modification with that of usual medical care.
Archives of Internal MedicineReport of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel
539 Citations1988DeWitt S. Goodman, Stephen B. Hulley +27 more
Annals of Internal MedicineCholesterol and Coronary Heart Disease: Predicting Risks by Levels and Ratios
516 Citations1994Bruce Kinosian, Henry Glick +1 more
To better understand the value of the total cholesterol/HDL ratio as a summary measure of risk for coronary heart disease, the ability of this ratio to predict persons who will and will not develop coronaryHeart disease was examined, using statistical tests to compare this ratio with other cholesterol measures.
Clinical ChemistryQuantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2.
397 Citations1983Gerd Assmann, H Schriewer +2 more
A modified phosphotungstic acid/MgCl2 precipitation procedure for the precipitation of apolipoprotein B-containing lipoproteins is complete, with negligible coprecipitation of high-density lipoprotein subfractions (HDL1, HDL2, HDL3), even in hypertriglyceridemic sera.
New England Journal of MedicineDiscontinuation of Antihyperlipidemic Drugs — Do Rates Reported in Clinical Trials Reflect Rates in Primary Care Settings?
380 Citations1995Susan E. Andrade, Alexander M. Walker +5 more
The effectiveness and tolerability of antihyperlipidemic medications should be studied further in populations that typically use the agents, and in open-label studies were similar to those in the HMOs.
New England Journal of MedicineThe Efficacy of Intensive Dietary Therapy Alone or Combined with Lovastatin in Outpatients with Hypercholesterolemia
301 Citations1993Donald B. Hunninghake, Evan A. Stein +12 more
The effects of the low-fat-low-cholesterol diet and lovastatin on lipoprotein levels were independent and additive, and the reduction in LDL cholesterol produced by the diet was small, and its benefit was possibly offset by the accompanying reduction in the level of HDL cholesterol.
CirculationCost and health implications of cholesterol lowering.
211 Citations1992Lee Goldman, David J. Gordon +6 more
High priority should be given to research that could validate these cost-effectiveness projections as well as to further studies of the elderly and women, in whom direct data on the precise costs, risks, and benefits of interventions to lower cholesterol remain sparse.
Clinical ChemistryManual and continuous-flow colorimetry of triacylglycerols by a fully enzymic method.
138 Citations1979R E Megraw, Dorothy E Dunn +1 more
The procedure is sensitive, has good precision and accuracy, and gives results that compare well with chemical and enzymic commercial kit methods.
CirculationLow rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.
137 Citations1991Melanie Cohen, Michael Byrne +3 more
Only a small proportion of patients with documented coronary artery disease and hypercholesterolemia were being actively treated for their lipid disorder, suggesting that the published treatment guidelines have not yet been fully accepted.
Archives of Internal MedicineComparative Effects of Lovastatin and Niacin in Primary Hypercholesterolemia
128 Citations1994D. Roger Illingworth
Lovastatin was better tolerated than niacin and both exerted favorable dose-dependent changes on the concentrations of plasma lipids and lipoproteins in patients with primary hypercholesterolemia.
PubMedRecent trends in the identification and treatment of high blood cholesterol by physicians. Progress and missed opportunities.
107 Citations1993Wayne H. Giles, Robert F. Anda +4 more
Archives of Internal MedicineReducing Low-Density Lipoprotein Cholesterol Levels in an Ambulatory Care System
86 Citations1995Judy Shaffer
Patients in the Lipid Clinic group were four times more likely to reach a National Cholesterol Education Program I goal of a low-density lipoprotein cholesterol level less than 3.36 mmol/L (130 mg/dL) than were comparable patients in the General Internal Medicine Clinic group.
CirculationExpanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins.
82 Citations1992Charles L. Shear, Frank A. Franklin +6 more
In patients with initially high levels of triglycerides and low levels of HDL cholesterol, the elevation of LDL cholesterol produced by lovastatin appears to be enhanced, and patient characteristics had very little impact of clinical importance on the dose-dependent LDL cholesterol lowering found with Lovastatin.
JAMARecent Trends in the Identification and Treatment of High Blood Cholesterol by Physicians
76 Citations1993Wayne H. Giles
Better use of clinical opportunities to screen for HBC could substantially accelerate the progress in identifying persons, young adults in particular, who are likely to benefit from cholesterol reduction.
PubMedCholesterol treatment practices of primary care physicians.
51 Citations1992D. J. Hyman, Edward Maibach +2 more
The results indicate that physicians' personal health behaviors and self-efficacy should be addressed in interventions to modify cholesterol-related practice behavior.
The American Journal of CardiologyEvaluation of the effectiveness of lipid-lowering therapy (bile acid sequestrants, niacin, psyllium and lovastatin) for treating hypercholesterolemia in veterans
50 Citations1993Gordon Schectman, Jan Hiatt +1 more
Niacin and lovastatin are effective drugs for hypercholesterolemia management in the Veterans Administration Medical Center setting and may differ from that measured in randomized controlled trials.
Archives of Internal MedicineTreatment of Hypercholesterolemia by a Clinical Nurse Using a Stepped-Care Protocol in a Nonvolunteer Population
50 Citations1988Timothy P. Blair
A cholesterol clinic was established to determine whether a simple protocol would be effective in a nonvolunteer population referred by practicing cardiologists, and this method of treatment was effective and may serve as a model for the management of large numbers of patients with type II hyperlipidemia.
Archives of Internal MedicineComparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial
49 Citations1994D. Roger Illingworth
The efficacy and safety of lovastatin and niacin were compared in a controlled, randomized, open-label study of 26 weeks' duration that was conducted at five lipid clinics.
PubMedSaturated fats, cholesterol, and dietary compliance.
44 Citations1992Y Henkin, D W Garber +2 more
Annals of PharmacotherapyTelephone Contacts Do Not Improve Adherence to Niacin or Bile Acid Sequestrant Therapy
40 Citations1994Gordon Schectman, Janet Hiatt +1 more
Telephone contacts do not improve either adherence or tolerance to niacin or BAS, and alternative approaches to enhance acceptance of these medications requires further evaluation.
American Heart JournalBlood cholesterol treatment attitudes of community physicians: A major problem
35 Citations1988H. Robert Superko, Denise A. Desmond +3 more
Results show that treatment habits among medical specialties are similar with a tendency for lower initial treatment levels in the subspecialties of endocrinology and cardiology, and that physician treatment attitudes require substantial change if the NIH cholesterol consensus conference goals are to be achieved.
Archives of Internal MedicineSaturated Fats, Cholesterol, and Dietary Compliance
33 Citations1992Yaakov Henkin
The results suggest the long-term compliance to the reduction of dietary saturated fat remains a problem, even in individuals who receive intensive initial training and show an early favorable response.
Archives of Internal MedicineBarriers to Following National Cholesterol Educational Program Guidelines
29 Citations1992KATHLEEN N. Fix
Lowering the cholesterol level decreases mortality from CHD by 2% for every 1% decrease in low-density lipoprotein (LDL) cholesterol, and multiple clinical trials also indicate that lowering the cholesterollevel can arrest the progression of established atherosclerosis and even lead to regression of lesions.
Journal of General Internal MedicinePrimary care clinician compliance with cholesterol treatment guidelines
24 Citations1991Joel M. Schectman, Elaine G. Elinsky +1 more
Compliance with National Cholesterol Education Panel guidelines for dietary counseling, but not drug therapy, was higher in this setting than in other published compliance studies.
American Journal of Preventive MedicinePatterns of Physicians’ Treatments for Referral Patients From Public Cholesterol Screening
16 Citations1991Lois A. Maiman, Philip Greenland +2 more
The results imply that current treatment guidelines may not be working and suggest the need for continued physician education in the management of hypercholesterolemia.
PubMedCombination drug therapy for hypercholesterolemia. The trade-off between cost and simplicity.
13 Citations1993Gustavo R. Heudebert, Jerome Van Ruiswyk +2 more
Archives of Internal MedicineCombination Drug Therapy for Hypercholesterolemia
11 Citations1993Gustavo R. Heudebert
Fulfillment of the target LDL-C approach recommended by the National Cholesterol Education Program often requires the use of multiple drugs, and when lovastatin is used initially, the regimen becomes simpler, albeit more expensive.